Patents by Inventor Keith HAYNES

Keith HAYNES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240279236
    Abstract: The present disclosure relates to various compounds and compositions which are useful for the treatment of tuberculosis and other diseases such as infections caused by Mycobacterium tuberculosis. The present disclosure also relates to various methods of using these compounds and compositions to treat tuberculosis and other diseases such as infections caused by Mycobacterium tuberculosis. Further, the present disclosure relates to processes of preparing these compounds and compositions.
    Type: Application
    Filed: May 9, 2022
    Publication date: August 22, 2024
    Applicants: Fimbrion Therapeutics, Inc., Washington University, Saint Louis University
    Inventors: James Janetka, Laurel Mydock-McGrane, Keith Haynes, Marvin J. Meyers
  • Patent number: 11092549
    Abstract: Described are compounds and methods useful in measuring membrane permeability and efflux transporter activity in bacteria, including multidrug resistance Gram negative bacteria.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: August 17, 2021
    Assignees: Saint Louis University, The Board of Regents of the University of Oklahoma
    Inventors: John K. Walker, Keith Haynes, Narges Abdali, Valentin V. Rybenkov, Helen I. Zgurskaya
  • Publication number: 20200018705
    Abstract: Described are compounds and methods useful in measuring membrane permeability and efflux transporter activity in bacteria, including multidrug resistance Gram negative bacteria.
    Type: Application
    Filed: May 22, 2019
    Publication date: January 16, 2020
    Inventors: John K. WALKER, Keith HAYNES, Narges ABDALI, Valentin V. RYBENKOV, Helen I. ZGURSKAYA